TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan adds generic Detrol, HIV/AIDS drugs

MYL $27.29 +$0.10

at close on THURSDAY

Daily Photo Galleries

Thursday, Nov. 29, 2012, 12:40 p.m.
 

Mylan Inc. said on Thursday that it had introduced a generic incontinence drug to the U.S. market and was selected by the South African government as a supplier of antiretroviral drugs.

Cecil-based Mylan has started selling Tolterodine Tartrate tablets, the generic version of Detrol, made by Pfizer Inc. Tolterodine Tartrate had U.S. sales of $61.5 million for the 12 months ended Sept. 30.

The company said the South African National Department of Health selected Mylan's Indian subsidiary to supply it with 31 percent of the 30 million units of HIV/AIDS drugs it will buy in a two-year period ending Dec. 31, 2014.

Mylan's share of the contract is valued at about $127.5 million.

Add Alex Nixon to your Google+ circles.

 

 

 
 


Show commenting policy

Most-Read Stories

  1. Penn State rolls past Massachusetts
  2. Lending challenges, rehab costs thwart efforts to revitalize
  3. Pitt blows 10-point lead as Iowa rallies for win
  4. Gas industry remedies ‘brain drain’ in Western Pennsylvania
  5. Hill District leaders irked as Penguins submit former Civic Arena site plan to city
  6. Hurricane shattered Charleston, S.C., tested mayor 25 years ago
  7. Climate change tops debt as budget threat, feds say
  8. Penguins notebook: Crosby sits, could be out ‘couple days’
  9. Pitt notebook: Boyd has breakout performance in loss
  10. Penguins notebook: Crosby practices, feels better
  11. Moore hopes to see red (zone) in Steelers debut
Subscribe today! Click here for our subscription offers.